Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Health Economics, Policy, and Law|March 4, 2020
The 'Netflix plus model': can subscription financing improve access to medicines in low- and middle-income countries?Avi Cherla, Natasha Howard, Elias Mossialos
Eclinicalmedicine|January 13, 2021
Cost-effectiveness of cancer drugs: Comparative analysis of the United States and EnglandAvi Cherla, Matthew Renwick, Ashish Jha, et al.
JAMA Internal Medicine|February 22, 2021
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated ApprovalAvi Cherla, Huseyin Naci, Aaron S Kesselheim, et al.
Clinical Pharmacology and Therapeutics|June 6, 2022
Post-Marketing Requirements for Cancer Drugs Approved by the European Medicines Agency, 2004-2014Avi Cherla, Elias Mossialos, Maximilian Salcher-Konrad, et al.
PLOS Digital Health|November 8, 2023
A Framework for Digital Health Policy: Insights from Virtual Primary Care Systems Across Five NationsDivya Srivastava, Robin Van Kessel, Marine Delgrange, et al.
Health Affairs (Project Hope)|July 7, 2025
New Cancer Drug Approvals: Less Than Half Of Important Clinical Trial Uncertainties Reported By The FDA To Clinicians, 2019-22Avi Cherla, Steven Woloshin, Anita K Wagner, et al.
The Lancet Regional Health. Europe|October 14, 2024
Trends in avoidable mortality from cardiovascular diseases in the European Union, 1995-2020: a retrospective secondary data analysisAvi Cherla, Ilias Kyriopoulos, Pauline Pearcy, et al.
The Lancet. Oncology|June 3, 2023
Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional studyKristina Jenei, Adam J N Raymakers, Arnaud Bayle, et al.
Pageof 1